*CXO Demand Growth and Order Recovery,Hwabao WP CSI Medical Service ETF(512170) Up 1.31%, Aiming for Fourth Consecutive Gain
NewTimeSpace News - As of 09:40 on January 13, 2026, Medical ETF (512170) rose 1.31%, aiming for its fourth consecutive gain, with the latest price at 0.39 yuan. Over a longer timeframe, as of January 12, 2026, Medical ETF accumulated a 6.42% gain over the past week. (The stocks listed above are index constituents only and do not constitute specific recommendations.)
In terms of liquidity, Medical ETF recorded an intraday turnover rate of 1.21% and trading volume of 347 million yuan. Over a longer period, as of January 12, its average daily trading volume reached 933 million yuan over the past week, ranking first among comparable funds.
Scale-wise, Medical ETF's latest size hit 27.747 billion yuan, hitting a three-month high and ranking 1st out of 4 comparable funds. (Data source: Wind)
In terms of shares outstanding, Medical ETF's share count grew 4.547 billion units over the past three months, achieving significant growth and ranking 1st out of 4 comparable funds. (Data source: Wind)
Data shows leveraged funds continue to build positions. Medical ETF's previous day net margin purchase reached 7.3414 million yuan, with the latest margin balance at 881 million yuan. (Data source: Wind)
As of January 12, Medical ETF's NAV rose 25.54% over the past year. In terms of return capability, as of January 13, 2026, since its inception, the ETF's highest monthly return was 29.81%, longest consecutive up months was 6, longest consecutive gain was 26.58%, and average return in up months was 6.86%. As of January 13, 2026, its excess return over benchmark since inception was 1.76% annualized.
On drawdowns, as of January 13, 2026, Medical ETF's year-to-date maximum drawdown was 0.00%, with a relative benchmark drawdown of 0.08%.
In terms of fees, Medical ETF charges a management fee of 0.50% and a custody fee of 0.10%.
Regarding tracking accuracy, as of January 13, 2026, Medical ETF's five-year tracking error was 0.038%, the highest tracking precision among comparable funds.
Medical ETF closely tracks the CSI Healthcare Index. The CSI Healthcare Index selects listed securities of companies in the healthcare industry whose business involves medical devices, medical services, medical informatization, and other healthcare themes as index samples to reflect the overall performance of healthcare-themed listed securities.
Ping An Securities stated that in the CXO and upstream sectors, pharmaceutical financing saw slight growth, while BD transactions and H-share IPO recovery have activated innovation enthusiasm, with orders showing signs of recovery. Outbound CXO demand is growing, and inbound CXO orders are rebounding, recommending attention to SMO, preclinical CRO, and other fields. The device industry is under short-term pressure from policies, but fundamentals are expected to improve as anti-involution policies are introduced, centralized procurement clears, and companies upgrade innovation and expand international business.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.